• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Allison Transmission Inc. Product Image

Allison Transmission Inc.

  • ID: 1785733
  • October 2008
  • Standard & Poors


  • Allison Transmission Inc.
  • MORE

Good profitability Strong market shares Fair diversity among truck, bus, off-highway, and military markets Highly leveraged balance sheet Cyclical and currently very weak truck industry demand Limited geographic diversity High fixed costs The ratings on Indianapolis-based Allison Transmission Inc. reflect the company's highly leveraged financial risk profile, which more than offsets the company's good profitability, strong market shares, and fair end-market diversity as a leading supplier of automatic transmissions for commercial vehicle, off-highway, and military applications. Standard & Poor's Ratings Services considers Allison's business risk profile to be weak, reflecting primarily the cyclicality of the North American commercial vehicle supplier business, which is currently in a severe downturn. The weak U.S. economy has led to lower freight volumes, which, coupled...

Companies mentioned in this report are: Allison Transmission Inc.
Action: Review

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research Type: Full Analysis

Note: Product cover images may vary from those shown

Allison Transmission Inc.

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown


Our Clients

Fluidigm Corporation Apple, Inc. CEVA Santé Animale Abbott Laboratories Ltd. Merck Group Allergan Inc. Pfizer, Inc.